NEW YORK (TheStreet) -- Genetic Technologies shares are up 13.2% to $1.16 on Monday after the company announced that the number of BREVAGen breast cancer risk test samples it received this quarter was up 37% over the previous quarter.The company...
MELBOURNE, AUSTRALIA -- (Marketwired) -- 05/28/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) is pleased to announce the appointment of Mr Eutillio Buccilli to the role of Chief Financial Officer, effective 2 June 2014.
After news broke that Apple was in late stage talks to acquire Beats Audio for $3.2 billion, Piper Jaffray analyst Gene Munster put out a note.
Munster is not into this deal. He says, it "sounds like a bad deal." He adds:
Technologies Limited (NASDAQ: GENE) today announced it has
filed its Quarterly Activities Report for the Quarter ended March 31,
2014 in accordance with the ASX.
Total cash receipts from customers during the quarter ended March 31,
MELBOURNE, AUSTRALIA -- (Marketwired) -- 04/17/14 -- Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) advises that an Extraordinary General Meeting of shareholders was held at 10.00 am today (Melbourne time).
Shareholders were asked...
Based in Alachua, FL, Applied Genetic Technologies (AGTC) scheduled a $50 million IPO on the Nasdaq with a market capitalization of $179 million at a price range midpoint of $14 for Thursday, March 27, 2014.
The full IPO calendar...
WASHINGTON (dpa-AFX) - Applied Genetic Technologies Corp. said Wednesday
that it has priced its initial public offering of 4,166,667 shares of its common
stock at a price to the public of $12.00 per share, which is below its
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.
You may also be interested in articles related to GENETIC TECHNOLOGIES (GENE):